Last Week’s Top 3 Most Read Posts on Pulmonary Hypertension

0
(0)

ph top 3

Read the articles here:

1. PAH Drug Associated with Fewer Deaths, Disease Complications in Phase 3 Study

2. New PAH Drug from Actelion Approved by FDA

3. Reata PH Study Expands to Include Patients with Interstitial Lung Disease

 

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *

Pin It on Pinterest

Share This